The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArcontech Group Regulatory News (ARC)

Share Price Information for Arcontech Group (ARC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 106.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 3.00 (2.857%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 106.50
ARC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

5 Mar 2020 07:00

RNS Number : 0594F
Arcontech Group PLC
05 March 2020
 

 

 

 

ARCONTECH GROUP PLC

 

("Arcontech" or the "Group")

 

INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2019

 

Arcontech (AIM: ARC), the provider of products and services for real-time financial market data processing and trading, is pleased to report its unaudited results for the six months ended 31 December 2019.

 

 

Highlights:

 

· Turnover increased by 7.5% to £1,473,651 (six months ended 31 December 2018: £1,371,107)

· Profit before tax increased by 22% to £551,847 (six months ended 31 December 2018: £452,756)

· Adjusted profit before tax (before release of accruals for administrative costs in respect of prior years but including share based payments) increased by 52% to £509,347 (six months ended 31 December 2018: £335,470)

· Annual run-rate of recurring revenues at 31 December 2019 increased by 3% to £2.87 million (at 31 December 2018: £2.78 million)

· Cash of £4,400,455 as at 31 December 2019 (31 December 2018: £3,231,830)

· Trading in line and on track to meet full year market expectations

 

 

Richard Last, Chairman of Arcontech Group, said:

 

"The Board is pleased with Arcontech's growth in revenue and adjusted profit before tax. Cash at the half year was £1,168,625 higher than the previous half year, further strengthening the Balance Sheet and demonstrating the cash generative and robust nature of the business. We have continued to invest in product development to add value to existing and prospective clients whilst making our products more competitive and compelling when compared with alternatives. Whilst there remain global factors that can affect our always long and unpredictable sales cycle, we remain positive about the Group's long term prospects and the Board expects results for the full year to be in line with expectations."

 

 

Enquiries:

 

Arcontech Group plc

020 7256 2300

Richard Last, Chairman and Non-Executive Director

Matthew Jeffs, Chief Executive

finnCap Ltd (Nomad & Broker)

020 7220 0500

Carl Holmes/Simon Hicks

Camille Gochez - ECM

 

To access more information on the Group please visit: www.arcontech.com

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

The interim report will only be available to view online enabling the Group to communicate in a more environmentally friendly and cost-effective manner.

 

Chairman's Statement

 

I am pleased to report that Arcontech has continued to grow profits in the six-month period ended 31 December 2019 in line with expectations, reporting an adjusted profit before tax of £509,347 (six months ended 31 December 2018: £335,470) an increase of 52%. Turnover increased by 7.5% to £1,473,651 compared to the corresponding six-month period in 2018 where turnover amounted to £1,371,107. This reflects the growth in recurring annual licence fees, primarily from existing customers, which on an annualised basis amounted to £2.87 million at 31 December 2019, compared to £2.78 million as at 31 December 2018. Declared fully diluted earnings per share were 4.17 pence per share compared to 3.72 pence per share for the corresponding period last year, while adjusted fully diluted earnings per share increased by 36% to 3.85p over the same period.

 

During the half year to 31 December 2019 Arcontech's increase in revenues reflects the full year effect of sales made during the year to 30 June 2019 and the impact of selling more Excelerator Add-in's into the existing customer base. During the half year and in the run up to Brexit we did notice decisions being put on hold as clients considered their options. That said, we continue to trial our Desktop software solution with a number of blue chip organisations and usage has increased by approximately 71% to 120 (70 in December 2018). We also added a new client user. Excelerator users have remained stable.

 

For the server-side of the business which consists of our MVCS (Multi-Vendor Contribution System) and Real-time Cache, we have continued developments to provide visualisation of data throughput, which is in Alpha-test and for which client feedback is very positive. This will make our server-side software more competitive and add value in terms of faster identification and resolution of any data or performance issues thus reducing risk for the client.

 

Financing

 

The Group has a strong financial position with cash balances at the 31 December 2019 of £4,400,455 (31 December 2018 £3,231,830), an increase of £1,168,625, providing a sound basis for continued investment in the business and demonstrating the cash generative nature of the business. The increase in cash between 30 June 2019 and 31 December 2019 principally reflects net cash inflows from operations less dividends paid to shareholders during the period.

 

Dividend

 

No interim dividend is proposed to be paid in respect of the half year.The Board does expect to continue its policy of paying a dividend following the announcement of its full year results.

 

Employees

 

I would like to thank our employees and directors for their continued hard work and dedication, which I know is appreciated by our customers and shareholders alike.

 

Outlook

 

Arcontech has a robust business base supported by a high level of recurring revenues and a strong balance sheet. Our business is international with customers operating in the UK, Europe, the USA, Hong Kong and Singapore. We propose to maintain ongoing investment in product development and to bolster our sales efforts. As we repeatedly note in our statements to shareholders we remain mindful of the long and unpredictable sales cycles we often face and the challenges this brings in predicting the timing of contract wins. The Board is also currently monitoring the Coronavirus and assessing the possible impact on the Group's business. While there has been no impact to date, if the spread of the virus is prolonged it may lead to companies delaying capital expenditure, which may reduce new business. There is expected to be no impact on existing revenues. That said, the Board views the long term future for the business with optimism and in the short term expects results for the full year to be in line with market expectations.

 

 

Richard Last

Chairman and Non-Executive Director

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GROUP INCOME STATEMENT AND STATEMENT OF COMPREHENSIVE INCOME

 

Note

Six months ended 31

 December

Six months ended 31

 December

Restated*

Year ended

30 June

2019

2018

2019

£

£

£

Revenue

1,473,651

1,371,107

2,841,362

Administrative costs

(924,211)

(931,902)

(1,936,829)

Operating profit

4

549,440

439,205

904,533

Finance income

16,573

13,551

27,184

Finance costs

(14,166)

-

-

Profit before taxation

551,847

452,756

931,717

Taxation

6

9,734

45,318

60,318

 

Profit for the period after tax

 

 

561,581

498,074

 

992,035

Total comprehensive income

561,581

498,074

992,035

Profit per share (basic)

4.25p

3.77p

7.40p

Adjusted** Profit per share (basic)

3.93p

2.88p

6.88p

Profit per share (diluted)

4.17p

3.72p

7.30p

Adjusted** Profit per share (diluted)

3.85p

2.84p

6.79p

 

* See note 11

 

**Adjusted to exclude the release of accruals for administrative expenses in respect of prior years

 

All of the results relate to continuing operations.

GROUP BALANCE SHEET

 

 

Note

 

31 December 2019

 

31 December 2018

Restated*

30 June

2019

£

£

£

Non-current assets

Goodwill

1,715,153

1,715,153

1,715,153

Property, plant and equipment

17,084

11,398

15,011

Right of use asset

10

588,212

-

-

Deferred tax asset

285,000

270,000

285,000

Trade and other receivables

141,750

141,750

141,750

Total non-current assets

2,747,199

2,138,301

2,156,914

Current assets

Trade and other receivables

608,910

320,608

263,875

Cash and cash equivalents

4,400,455

3,231,830

4,063,484

Total current assets

5,009,365

3,552,438

4,327,359

Current liabilities

Trade and other payables

(694,215)

(769,105)

(682,420)

Deferred income

(1,513,941)

(801,409)

(1,151,545)

Lease liabilities

10

(162,000)

-

-

Total current liabilities

(2,370,156)

(1,570,514)

(1,833,965)

Non-current liabilities

Lease liabilities

10

(392,405)

-

-

Total non-current liabilities

(392,405)

-

-

Net current assets

 2,639,209

 1,981,924

2,493,394

Net assets

4,994,003

4,120,225

4,650,308

Equity

Share capital

1,651,314

1,651,314

1,651,314

Share premium account

56,381

56,381

56,381

Share option reserve

145,352

74,101

99,647

Retained earnings

3,140,956

2,338,429

2,842,966

4,994,003

4,120,225

4,650,308

* See note 11

 

GROUP CASH FLOW STATEMENT

 

Note

Six months ended 31

December

Six months ended 31

December

Year ended

30 June

2019

2018

2019

£

£

£

 

 

Cash generated from operating activities

9

661,027

136,562

 

 

966,060

Tax recovered

9,734

45,318

45,318

Net cash generated from operating activities

670,761

181,880

 

1,011,378

Investing activities

Interest received

16,573

13,551

27,184

 

Purchases of plant and equipment

 

(5,772)

 

(2,325)

 

 (13,802)

Net cash generated from investing activities

 

10,801

 

11,226

 

13,382

Financing activities

Dividends paid

(263,591)

(171,334)

(171,334)

Payment of lease liabilities

(81,000)

-

-

Net cash used in financing activities

(344,591)

(171,334)

(171,334)

 

 

Net increase in cash and cash equivalents

 

 

336,971

 

 

21,772

 

 

853,426

Cash and cash equivalents at beginning of period

 

4,063,484

 

3,210,058

 

3,210,058

Cash and cash equivalents at end of period

4,400,455

3,231,830

4,063,484

 

 

 

 

 

 

GROUP STATEMENT OF CHANGES IN EQUITY 

 

Share

capital

Share

premium

Share-based paymentsreserve

Retained

earnings

 Total

 

£

£

£

£

£

At 1 July 2018

1,651,314

56,381

56,366

2,011,689

3,775,750

Total comprehensive income for the period

 

-

 

 

-

 

 

-

 

 

498,074

 

498,074

Dividends paid

-

-

-

(171,334)

(171,334)

Share-based payments

-

-

17,735

-

17,735

At 31 December 2018

1,651,314

56,381

74,101

2,338,429

4,120,225

Total comprehensive income for the period

 

 

 

 

 

 

-

 

 

-

 

 

-

 

 

493,961

 

493,961

 

Share-based payments

 

-

 

-

 

36,122

 

-

36,122

Realisation of share option reserve

 

-

 

-

 

(10,576)

 

10,576

-

At 30 June 2019

1,651,314

56,381

99,647

2,842,966

4,650,308

Total comprehensive income for the period

 

 

 

-

 

 

-

 

 

-

 

 

561,581

 

561,581

Dividends paid

-

-

-

(263,591)

(263,591)

Share-based payments

 

-

-

 

45,705

 

 

-

 

45,705

 

At 31 December 2019

1,651,314

56,381

145,352

3,140,956

4,994,003

 

 

 

 

 

 

NOTES TO THE FINANCIAL INFORMATION

 

1. The figures for the six months ended 31 December 2019 and 31 December 2018 are unaudited and do not constitute statutory accounts. The interim results have been prepared using accounting policies which are consistent with International Financial Reporting Standards as adopted by the European Union and are expected to be adopted in the next annual accounts. IFRS 16 Leases has been applied for the first time in preparing the interim financial information. Note 10 sets out the key impacts on the Statement of Comprehensive Income and the Statement of Financial Position of the adoption of the new standard.

2. The financial information for the year ended 30 June 2019 set out in this interim report does not comprise the Group's statutory accounts as defined in section 434 of the Companies Act 2006. The statutory accounts for the year ended 30 June 2019, which were prepared under International Financial Reporting Standards (IFRS) as adopted for use in the EU, applied in accordance with the provisions of the Companies Act 2006, have been delivered to the Registrar of Companies. The auditors reported on those accounts; their report was unqualified and did not contain a statement under either Section 498(2) or Section 498(3) of the Companies Act 2006 and did not include references to any matters to which the auditor drew attention by way of emphasis. The auditors have not reported on the restatement of the information for the year ended 30 June 2019 as explained in note 11.

3. Copies of this statement are available from the Company Secretary at the Company's registered office at 1st Floor 11-21 Paul Street, London, EC2A 4JU or from the Company's website at www.arcontech.com.

4. Operating profit is stated after release of accruals for administrative expenses in respect of prior years of £42,500 (31 December 2018: £117,286; 30 June 2019: £156,786).

5. Earnings per share have been calculated based on the profit after tax and the weighted average number of shares in issue during the half year ended 31 December 2019 of 13,210,510 (31 December 2018: 13,210,510; 30 June 2019: 13,210,510).

The number of dilutive shares under option at 31 December 2019 was 256,341 (31 December 2018: 189,343; 30 June 2019: 165,223). The calculation of diluted earnings per share assumes conversion of all potentially dilutive ordinary shares, all of which arise from share options. A calculation is done to determine the number of shares that could have been acquired at the average market price during the period, based upon the issue price of the outstanding share options including future charges to be recognised under the share-based payment arrangements.

6. Taxation is based on the unaudited results and provision has been estimated at the rate applicable to the Company at the time of this statement and expected to be applied to the total annual earnings. No corporation tax has been charged in the period as any liability has been offset against tax losses brought forward from prior years. The tax credit represents the cash recovery of Research & Development tax credits during the period.

7. A final dividend in respect of the year ended 30 June 2019 of 2.0 pence per share (2018: 1.3 pence per share) was paid on 11 October 2019.

8. The Directors have elected not to apply IAS34 Interim financial reporting.

 

 

9. Cash generated from operations

Six months ended 31

December

Six months ended 31

December

Year ended

30 June

 

2019

2018

2019

 

£

£

£

 

 

Operating profit

549,440

439,205

904,533

 

 

Depreciation charge

77,226

8,868

16,732

 

 

Non-cash share option charges

45,705

17,735

53,857

 

 

Adjustment for adoption of IFRS 16

(40,500)

-

-

 

 

(Increase)/decrease in trade and other receivables

(345,035)

(10,485)

 

 

46,248

 

 

Increase/(Decrease) in trade and other payables

374,191

(318,761)

 

(55,310)

 

 

 

Cash generated from operations

661,027

136,562

966,060

 

 

 

10. Adoption of accounting standard IFRS 16

 

The Group has adopted IFRS 16 using the modified retrospective approach with the effect of applying this standard at the date of initial recognition of 1 July 2019, consequently comparatives have not been restated.

 

As a lessee, the Group has previously classified leases as operating or finance leases based on whether the lease transferred significantly all of the risks and rewards incidental to the ownership of the underlying asset. Under IFRS 16, the Group recognises right-of-use assets and lease liabilities for all leases on its balance sheet. The only lease applicable under IFRS 16 is the Group's office.

 

The key impacts on the Statement of Comprehensive Income and the Statement of Financial Position are as follows:

 

Right of use asset

£

 

Prepayments

 

£

 

Lease liability

£

 

Income statement

£

As at 1 July 2019

-

 

-

 

-

 

-

 

 

 

 

 

 

 

 

Recognised on adoption of IFRS 16

661,739

 

(40,500)

 

(621,239)

 

-

Depreciation

(73,527)

 

-

 

-

 

(73,527)

Interest

-

 

-

 

(14,166)

 

(14,166)

Lease payments

-

 

-

 

81,000

 

81,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Carrying value at 31 December 2019

588,212

 

(40,500)

 

(554,405)

 

(6,693)

 

 

 

 

 

 

 

 

 

 

11. Revision to revenue recognition policy under IFRS 15

IFRS 15 "Revenue from contracts with customers" was adopted from 1 July 2018 in line with transitional provisions provided in the new standards. The audited financial statements for the year ended 30 June 2019 recognised revenue from recurring license fees on an 'at a point in time' basis. The Group has undertaken a further review and analysis of its offering and performance obligations under the terms of recurring license fee contracts. The conclusion reached is that in the context of IFRS 15 the correct approach for the recognition of revenue is on an over time basis whereby deferred income arises upon entering into a license fee agreement and is then subsequently recognised as revenue across the remaining passage of time on the license.

This is consistent with the Group's approach to revenue recognition for recurring license fees prior to the introduction of IFRS 15.

The interim report for the six months ended 31 December 2018 reported revenue on an over time basis and accordingly there have been no changes to six month comparatives presented in this report.

The comparatives for the twelve month period to 30 June 2019 have been restated in this report to recognise revenue from recurring license fee contracts on an over time basis. The effect of this change on the trading result for the twelve months to 30 June 2019 as a result of this change in revenue recognition policy is shown below.

Group Income Statement and Statement of Comprehensive Income:

Revenue decreased by £125,426

Profit for the year before taxation and after taxation decreased by £125,426

 

Statement of Changes in Equity:

Total comprehensive income for the year at 30 June 2019 decreased by £125,426

Retained earnings at 30 June 2019 decreased by £1,151,545

 

Group Balance Sheet:

Deferred income increased by £1,151,545

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR FFFIFVTISIII
Date   Source Headline
21st Feb 20247:00 amRNSInterim Results
27th Oct 20237:00 amRNSNew Client Win
25th Oct 20231:42 pmRNSResult of AGM
3rd Oct 20235:40 pmRNSPosting of Annual Report & Notice of AGM
5th Sep 20237:00 amRNSFinal Results
24th Jul 20237:00 amRNSTrading Update and Notice of Results
10th May 20237:00 amRNSAppointment of consultant in Singapore
6th Apr 202311:45 amRNSDirector/PDMR Shareholding
3rd Apr 20237:00 amRNSDirector Retirement
27th Feb 20237:00 amRNSInterim Results
26th Oct 20223:15 pmRNSBoard Appointment
21st Oct 20227:00 amRNSGrant of Options
17th Oct 20222:41 pmRNSResult of AGM
17th Oct 20222:41 pmRNSResult of AGM
23rd Sep 20224:30 pmRNSPosting of Annual Report & Notice of AGM
12th Sep 20227:00 amRNSFinal Results
30th Aug 20227:00 amRNSNotice of Results
29th Jun 20227:00 amRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSInterim Results
17th Jan 20224:30 pmRNSDirector/PDMR Shareholding
29th Nov 20219:06 amRNSSecond Price Monitoring Extn
29th Nov 20219:00 amRNSPrice Monitoring Extension
29th Nov 20217:00 amRNSTrading Update
15th Oct 20215:32 pmRNSDirector/PDMR Shareholding
12th Oct 20215:00 pmRNSGrant of Options
11th Oct 20217:00 amRNSHolding(s) in Company
1st Oct 20213:30 pmRNSResult of AGM
8th Sep 20217:00 amRNSPosting of Annual Report & Notice of AGM
8th Sep 20217:00 amRNSExercise of Options
7th Sep 20217:00 amRNSExercise of Options, Director/PDMR Shareholding
1st Sep 20214:41 pmRNSSecond Price Monitoring Extn
1st Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSFinal Results
10th Aug 20217:00 amRNSNotice of Results
12th Mar 202112:16 pmRNSHolding(s) in Company
23rd Feb 20217:00 amRNSInterim Results
22nd Jan 20214:30 pmRNSIssue of Equity
16th Oct 20207:00 amRNSAgreement to upgrade longstanding Tier 1 Client
5th Oct 20203:03 pmRNSGrant of Options
2nd Oct 202011:05 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSNew client win to contribute data to Factset
29th Sep 202010:53 amRNSResult of AGM
10th Sep 20207:00 amRNSIssue of Equity & PDMR Shareholding
8th Sep 20207:00 amRNSPosting of Annual Report & Notice of AGM
2nd Sep 20207:00 amRNSFinal Results
27th Aug 20201:59 pmRNSNotice of Results
20th Jul 20207:00 amRNSBoard appointment
15th Jul 20207:00 amRNSTrading Update / Notice of Results
1st Jun 20207:00 amRNSDirectorate change & Appointment of CoSec

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.